Michael Sporn, MD, emeritus professor of pharmacology and toxicology, and medicine, is featured in Nature Index 2017 for his tremendous impact upon biomedical research and drug development.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.
More than $12 million over five years has been awarded for research collaboration to more precisely determine lung cancer risk and improve screening.
Physician and scientist Steven D. Leach, MD, has been selected as the new Director of the Norris Cotton Cancer Center. The appointment was announced today by Dr. Duane Compton, dean of the Geisel School of Medicine at Dartmouth, and Dr. James N. Weinstein, CEO and President of Dartmouth-Hitchcock.
Large study co-led by Geisel professor Christopher Amos, PhD, identified several new variants for lung cancer risk that will translate into improved understanding of the mechanisms involved in lung cancer risk.
Louise Davies, MD, MS, an associate professor of surgery and of The Dartmouth Institute, is one of two Dartmouth faculty to have been named Fulbright Scholars for the 2017-2018 academic year, enabling their planned teaching and research activities abroad.
Konstantin Dragnev, MD, a practicing oncologist at the Dartmouth-Hitchcock Norris Cotton Cancer Center and a translational scientist, has been named the Irene Heinz Given Professor in Pharmacology.
A new Dartmouth study shows that travel time is not a deterrent to radiation therapy for treatment of prostate cancer in New Hampshire.
Arminja Kettenbach, PhD, an assistant professor of Biochemistry and Cell Biology at Geisel, recently received two high-profile grant awards to support her research in proteomics, which is shedding new light on what goes wrong in cell division during cancer.
Research published in the journal Nature Communications describes distribution of a DNA defect in the glioblastoma genome and its relationship with patient survival.